Aker Biomarine AS (AKBM) — Capital Reinvestment Ratio
Aker Biomarine AS (AKBM) has a Capital Reinvestment Ratio of 1.70x as of December 2024, meaning it reinvests 2% of its operating cash flow (Nkr7.60 Million) in capital expenditures (Nkr12.90 Million). See Aker Biomarine AS net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aker Biomarine AS Capital Reinvestment Ratio (2016–2024)
This chart tracks Aker Biomarine AS's Capital Reinvestment Ratio across 8 annual periods. Check total reinvestment intensity of Aker Biomarine AS to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Aker Biomarine AS (2016–2024)
Year-by-year Capital Reinvestment Ratio for Aker Biomarine AS from 2016 to 2024. For live market cap and broader valuation context, see AKBM stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.89x | Nkr12.20 Million | Nkr23.10 Million | ▲ +82.0% |
| 2023 | 1.04x | Nkr47.40 Million | Nkr49.30 Million | ▼ -65.9% |
| 2022 | 3.05x | Nkr15.10 Million | Nkr46.10 Million | ▼ -97.3% |
| 2021 | 111.26x | Nkr729.00K | Nkr81.11 Million | ▲ +978.9% |
| 2019 | 10.31x | Nkr12.31 Million | Nkr126.92 Million | ▲ +26.2% |
| 2018 | 8.17x | Nkr7.89 Million | Nkr64.51 Million | ▼ -32.6% |
| 2017 | 12.12x | Nkr9.17 Million | Nkr111.20 Million | ▲ +2222.5% |
| 2016 | 0.52x | Nkr20.88 Million | Nkr10.90 Million | — |